“Simplicity is a great virtue but it requires hard work to achieve it and education to appreciate it. And to make matters worse: complexity sells better.”
– Edsger W. Dijkstra
From Washington, DC,
- Modern Healthcare reports,
- “House Democratic leader Hakeem Jeffries said he would push to expand Medicare and lower the program’s eligibility age as he detailed the party’s emerging legislative agenda at a Denver conference.
- “Jeffries outlined a Democratic House agenda centered on reversing Medicaid cuts, restoring ACA subsidies, and lowering Medicare’s eligibility age.
- “Senate passage of Medicare changes remains uncertain, as Republican filibuster support and a potential Trump veto pose significant obstacles.”
- Beckers Payer Issues notes,
- “U.S. Reps. Adrian Smith, R-Neb., and Debbie Dingell, D-Mich., introduced a bill that would create a five-year pilot for skilled nursing facility services to be administered at home, according to a Nov. 12 news release.
- “The Bringing Rehabilitation, Integrated Delivery and Greater Extended Care at Home Act, or BRIDGE Care at Home Act, would establish a Medicare “SNF-at-Home” program Jan. 1. Under the program, eligible entities could deliver SNF services at a patient’s home, as long as that patient already qualifies for SNF coverage under Medicare Part A. The release said Medicare currently covers qualifying skilled nursing care in a facility but lacks a comparable payment model for that care at home.
- “With the program, the standard of care must be the same for at-home and inpatient SNF treatment. The services would be paid for under current Medicare SNF payment rules, out of the Hospital Insurance Trust Fund.”
- Federal News Network adds,
- “House Democrats are looking to quash the Trump administration’s proposal for a governmentwide non-disclosure agreement for federal employees.
- “Reps. Greg Landsman (D-Ohio) and Raja Krishnamoorthi (D-Ill.) on Thursday introduced the No Disrupting Accountability (NDA) Act. The legislation, if enacted, would prohibit federal funding from being used to “develop, finalize, implement, administer or enforce” the administration’s blanket NDA proposal.
- “Government employees should never be silenced from exposing waste, fraud, abuse and corruption — and federal funds should never be used to allow it,” Landsman said. “Our bill will make sure taxpayer dollars protect the public interest.”
- The American Hospital Association News relates,
- “The Centers for Medicare & Medicaid Services Nov. 13 announced it will delay enforcement of its Medicaid community engagement requirements that are set for Jan. 1. CMS is providing states an optional hold harmless transition period through June 30, 2027, for continued preparation efforts. CMS said that states implementing the hold harmless period will assess whether individuals meet the requirements or are excluded from it, but they will not deny applications or disenroll eligible individuals solely for failure to meet the requirements. The community engagement requirements call for certain adults to complete 80 hours per month of “qualifying activities,” such as employment, education, community service or participation in a work program, or meet equivalent income thresholds.”
- Healthcare Dive tells us,
- “Federal agencies plan to hold a series of events where payers, providers and health IT developers can test electronic workflows for prior authorization as the federal deadline for some insurers to automate the process looms.
- “Hosted by the Office of the National Coordinator for Health IT and the CMS, the events will allow the organizations to test their software and identify gaps before a Jan. 1 deadline that requires health plans to support electronic prior authorizations.
- “The testing events will last 10 to 12 weeks, and interested organizations must register with the CMS by Nov. 20.”
- The American Hospital Association News adds,
- “The AHA Nov. 13 released “Interoperability and Prior Authorization: The American Hospital Association’s 2027 Guide to Electronic Prior Authorization Go-live Readiness”. Along with the AHA’s new website on prior authorization, this new handbook is a collection of resources designed to help hospitals and health systems prepare for major provisions of the 2024 Interoperability and Prior Authorization final rule that go into effect on Jan. 1, 2027.”
From the U.S. Office of Personnel Management front,
- Federal News Network offers interviews with a bevy of experts about the ongoing Federal Employee Benefits Open Season.
- FedSmith reports,
- “The annual contribution limit for the Thrift Savings Plan (TSP) is increasing to $25,500 in 2027, according to an announcement from the Internal Revenue Service (IRS). This is a 4.1% increase over the 2026 limit of $24,500.” * * *
- “The catch-up contribution limit for employees aged 50 and older is rising to $8,500 in 2027, up from $8,000 in 2026, according to IRS Notice 2026-66. This means TSP participants who are 50 or older can contribute a total of $34,000 next year.
- “Under the SECURE 2.0 Act of 2022 (SECURE 2.0), employees aged 60, 61, 62 and 63 have a higher catch-up contribution limit. For 2027, that limit is increasing to $11,750, up from $11,250 in 2026. Participants in this age group can contribute up to $37,250 to the TSP in 2027.
- “Higher earners should keep in mind that catch-up contributions must be made to the Roth TSP if their prior-year wages exceed an IRS threshold. For 2027 catch-up contributions, that threshold is $155,000 in 2026 wages, up from $150,000 in 2025 wages for this year.”
- Govexec relates,
- “Transportation Secretary Sean Duffy on Thursday said he was puzzled that more young people aren’t interested in federal employment, even as his department has shed more than 4,000 employees since 2024.
- “I find it fascinating that more young people don’t want to apply,” he said. “We’re begging for people to come in.”
- “Duffy pitched federal employment at Texas Christian University in Fort Worth, as a guest speaker for Office of Personnel Management Director Scott Kupor’s college recruitment tour, part of his initiative to attract more early-career workers to the civil service.
- “The effort marks a shift for the Trump administration, which has spent much of the last two years shrinking the federal workforce. It is also the latest attempt by the government to address the historical underrepresentation of younger people in the civil service.
From the U.S. Food and Drug Administration front,
- MedTech Dive reports,
- “The Food and Drug Administration posted two early alerts on Tuesday for medical devices that are being removed from the market.
- “Teleflex subsidiary Arrow International recalled certain spring wire guide components used as part of a system to place catheters in blood vessels. Arrow told customers on Nov. 5 to quarantine and cease use and distribution for affected products, according to the FDA alert.
- “On the same day, the agency posted an alert for Intersurgical, which sent customers a letter on Nov. 3 recommending they immediately stop using certain breathing tubes and systems due to a manufacturing issue.”
- JAMA relates,
- “The US Food and Drug Administration (FDA) approved bepirovirsen, marketed as Hibsago, in combination with existing antiviral therapy for adults without cirrhosis who have chronic hepatitis B virus (HBV) infection.
- “The first-in-class drug is intended for patients who have received antiviral therapy for at least 6 months, have suppressed HBV viral DNA levels, and have hepatitis B surface antigen levels of 3000 IU/mL or less. The antisense oligonucleotide works by targeting viral genetic material and interfering with replication.
- “In 2 clinical trials, 24% of patients who received bepirovirsen met criteria to stop their background antiviral therapy, compared with none in the placebo group. About 6 months after stopping all hepatitis B treatment, nearly 20% of treated patients maintained viral control. Still, the drug carries a boxed warning for serious liver reactions and thrombocytopenia.”
No Surprises Act News,
- Healthcare Dive reports,
- “Senator Bill Cassidy, R-La., the outgoing chair of the Senate Health, Education, Labor and Pensions Committee, plans to soon release legislation reforming the No Surprises Act, according to a top aide.” * * *
- “Cassidy, one of the authors of the NSA, has been working on “comprehensive legislation” to restore the law’s key goals, including encouraging providers to go in-network with insurers and lowering healthcare costs broadly, Romney Gripado, a health policy advisor to Cassidy, said during a Thursday event hosted by the Georgetown University Center on Health Insurance Reforms in Washington, D.C.
- “Our proposal, which will be released soon, focuses on strengthening program integrity, improving oversight of [arbiters], restoring accountability, increasing transparency around the entire dispute resolution process, and ensuring that the dispute resolution process is fair and predictable for those involved,” Gripado said. “We’re also focused on protecting employers from unnecessary costs, ensuring that providers are compensated in a timely fashion, and addressing the incentives that might be driving increased utilization of arbitration.”
From the public health and medical / Rx research front,
- The Centers for Disease Control and Prevention announced today,
- “COVID-19, flu, and RSV are key indicators of overall respiratory illness activity
- “The amount of acute respiratory illness causing people to seek health care is low but increasing.
- “RSV activity is low in most areas of the country.
- “COVID-19 activity is low nationally.
- “Seasonal flu activity continues to increase in many parts of the country.
- “Rhinovirus/Enterovirus (RV/EV) and respiratory adenovirus (HAdV) are elevated nationally. Respiratory adenovirus is increasing in some regions of the country.”
- The American Hospital Association News reports,
- “Pennsylvania has recorded its seventh measles-associated death this year as a statewide outbreak of the virus continues, according to an update Nov. 13 by the state’s Department of Health. There are now 1,542 confirmed cases in the outbreak, with 305 hospitalizations. Nationwide, there are now 5,412 confirmed measles cases in 2026, according to data released Nov. 13 by the Centers for Disease Control and Prevention. The vaccination status of 96% cases is unvaccinated or unknown.”
- The Univerity of Minnesota’s CIDRAP adds,
- “With 174 new infections, Wisconsin reported the most measles cases of any US state over the past week.
- “In Pennsylvania, the country’s other major measles hot spot, officials confirmed 61 new infections over the past week. Its 2026 case count of 1,542 eclipses that of any other state.
- “A press release this afternoon from the Pennsylvania Department of Health (DOH) said that an unvaccinated resident in Montour County, located in east-central Pennsylvania, tested positive for measles and has died. No other information was given, with DOH citing privacy for the deceased.
- “It is the state’s seventh measles-associated death this year.” * * *
- “To Pennsylvania’s west, cases in Ohio increased by 61 infections this week, bringing the state’s 2026 total to 372. But West Virginia, which borders both Ohio and Pennsylvania, has had just two reported cases for all of 2026.
- “Unlike most states, West Virginia does not allow religious or philosophical belief exemptions for compulsory school vaccines. This has resulted in higher vaccination rates—CDC data show an estimated 98.9% of kindergartners received the MMR vaccine for the 2025-26 academic year.”
- and
- “Congenital syphilis rates among US newborns increased nearly sixfold from 2012 to 2022, according to a study published yesterday in Clinical Infectious Diseases. The data show rising rates across all demographics and income levels, with the sharpest increases among Native Americans.
- “Congenital syphilis occurs when a pregnant woman with untreated syphilis passes the infection to her baby. The infection can cause organ damage, skeletal abnormalities, neurodevelopmental impairment, stillbirth, and infant death.
- “For the study, researchers from Johns Hopkins University analyzed hospital records representing 14.6 million birth hospitalizations in 2012, 2016, 2019, and 2022, including an estimated 6,560 newborns diagnosed as having congenital syphilis.
- “The team found that congenital syphilis rates increased from 16.0 per 100,000 birth hospitalizations in 2012 to 94.7 per 100,000 in 2022, a 5.9-fold increase. The estimated number of affected newborns rose from 597 to 3,325 over that period.”
- Health Day tells us,
- “Ever start to fall asleep — and suddenly jolt awake?
- “It’s called a “sleep start,” or hypnic jerk. And new research links frequent episodes to anxiety and poor sleep.
- “Researchers surveyed nearly 200 adults and found those experiencing jolts at least once a week reported worse sleep quality, more insomnia symptoms and higher levels of anxiety and depression.
- “Participants reported more episodes during periods of emotional stress. Those with more negative thoughts about sleep also tended to startle awake more often.
- “Sleep starts are much more than a simple muscle twitch when falling asleep,” said lead author Tanja Grünberger, from Paris Lodron University in Salzburg, Austria.
- “Participants described sensations of falling, racing hearts, flashes of light, even loud bangs — sometimes accompanied by fear or panic.
- “Most drifted back to sleep quickly, but some experienced real distress.”
- The American Medical Association offers a rerun of its October 10, 2025, post about what doctors want patients to know about getting a good night’s sleep.
- The New York Times points out,
- “5 Muscles to Strengthen as You Age
- “We all know we need to strength train to move well and feel strong. But which exercises are the most important?”
- “5 Muscles to Strengthen as You Age
- Beckers Hospital Review informs us,
- “About six years ago, Northwell Health launched a school mental health pilot on Long Island with the goal of meeting children where they are, according to Scott Falkowitz, DO, a child and adolescent psychiatrist and medical director of the Northwell School Mental Health Program.
- “Today, the New Hyde Park, N.Y.-based system partners with school districts across Long Island and Westchester County. Its behavioral health center in Mount Kisco, N.Y., saw more than 1,100 new pediatric patients in its first year. Only nine were referred to an emergency department.
- “The need behind that work is broad: Dr. Falkowitz noted that about 1 in 5 young people have a mental health condition that significantly impairs their functioning.
- “For far too long, the emergency department has been the primary entry point in so many communities where accessing child and adolescent mental health services is in some places — and many places — literally impossible,” Dr. Falkowitz said. “For people who are in a behavioral health crisis, stepping into a loud, chaotic emergency department where there are traumas going on around you, where people are asking you the same question multiple times — you’re ultimately walking away with some guidance, but that important piece of making the connection to outpatient services is often missing.”
- “Under the partnership, a school counselor or psychologist with a student in crisis no longer has to default to an ambulance ride to the ED. Instead, the student can go to one of Northwell’s behavioral health centers.”
From the U.S. healthcare business and artificial intelligence front,
- Modern Healthcare reports,
- “Most major health insurers beat Wall Street expectations for their medical loss ratios in the third quarter.
- “Cost inflation has moderated from COVID-19 pandemic-era highs.
- “Oscar Health’s and Clover Health’s medical loss ratios improved the most during the third quarter.”
- and
- “Mayo Clinic named Dr. Matthew Callstrom its next president and CEO, succeeding Dr. Gianrico Farrugia who will retire at the end of the year.
- “Callstrom is the medical director for Mayo Clinic’s systemwide strategy and AI programs.”
- Beckers Hospital Review relates
- “During his Nov. 5 fireside chat at Becker’s CEO+CFO Roundtable, Mark Cuban urged health system leaders to point AI at their contracts and ask: “Where are they ripping me off?”
- “At Columbia, Mo.-based MU Health Care, that work is already underway, CFO Greg Damron said, speaking on a panel later that day. He said the system’s payer contracting team has become one of its leading adopters of the technology.
- “I think that’s been out of necessity trying to be able to ingest these large payer contracts, find all of the loopholes and dodges that are in there, all the policy updates,” Mr. Damron said.”
- and
- “Chicago-based CommonSpirit recorded an operating loss of $544 million (-5.3% operating margin) before special charges in the first quarter of fiscal 2027, which ended Sept. 30, according to its Nov. 13 financial report.”
- “Chicago-based CommonSpirit recorded an operating loss of $544 million (-5.3% operating margin) before special charges in the first quarter of fiscal 2027, which ended Sept. 30, according to its Nov. 13 financial report.”
- Fierce Health points out
- “Ardent Health is acquiring Boone Health, a mid-sized nonprofit system based in Columbia, Missouri, for $47 million in cash, the organizations announced Thursday. It marks Ardent’s first entry into the Missouri healthcare market.
- “The deal, expected to close in the first quarter of 2027, includes a 10-year, $200 million capital commitment on nonprofit Ardent’s part. That money will be invested in Boone’s facilities, workforce and, in the near term, an expansion of its emergency department, according to the announcement.
- “Ardent has agreed to maintain Boone’s essential hospital services while developing its 392-bed regional referral center, Boone Hospital Center. It also plans to maintain employment for existing Boone employees and providers, continue its charity care policy and establish a local advisory board.”
- The Wall Street Journal tells us
- “When CVS Health CVS said last week it would spin off its 9,000 drugstores, nobody cheered.
- “Critics of healthcare consolidation called it a political decoy that leaves the conflicts of vertical integration at the insurance conglomerate untouched. Wall Street had a different gripe: the pieces might be worth less apart. The stock lost some $15 billion in market value when the breakup was announced.
- “But selling pills and sunscreen out of labor-intensive stores is a very different business from managing drug benefits at Caremark, insuring patients at Aetna or dispensing specialty drugs. And the strategic advantages of owning those stores have diminished. If they no longer give the rest of CVS a meaningful edge, splitting them up might leave investors better off—even if it does nothing to appease lawmakers. * * *
- “Investors assumed the worst. Some feared the lost benefits of common ownership—lost synergies, in Wall Street parlance—could top $1 billion a year. At a Wolfe Research investor conference this week, CVS Chief Executive David Joyner said an analyst’s estimate of about $500 million a year was “much closer” to CVS’s own models. That helped lift the shares, though they are still trading slightly below where they stood before the Nov. 4 announcement. Whether existing contracts between the stores and pharmacy-benefit manager Caremark stay in place over the long term is another matter.
- “Regulation has steadily eroded the advantages of owning drugstores, Joyner said in an interview. Caremark’s benefit designs once drew members to CVS counters, but many states have moved to restrict such arrangements, and some have moved to ban common ownership of pharmacies and pharmacy-benefit managers, or PBMs, outright. So why keep a capital-intensive, slow-growing political headache?”
- Fierce Pharma informs us,
- “Over the last week, oral obesity medicines continued their upward trajectory, with both Eli Lilly’s Foundayo and Novo’s Wegovy pill scripts climbing to new heights.
- “Foundayo, in its 31st week since launch, saw its best uptake yet with 69K scripts—a 7% week-over-week jump—according to notes from Citi and Jefferies citing data from IQVIA. But Lilly’s oral option is still well behind Novo’s Wegovy pill launch pace, which hit 163K scripts at week 31 of its own rollout.
- “According to Jeffries, Foundayo is now making up for roughly 40% of new oral obesity prescriptions and 45% of the U.S. oral market’s incremental growth. Meanwhile, competition between the two metabolic rivals is expanding geographically as Lilly and Novo continue to launch their obesity pills into new markets.
- “For Novo’s part, week 42 of the Wegovy pill launch saw prescriptions climb slightly to 185K. Jeffries attributed a 72.8% overall oral market share to the Danish pharma’s pill, with Foundayo holding the remaining 27.2%.”
